Edit |   |
---|---|
Antigenic Specificity | Anthrax protective antigen, Bacillus anthracis (Raxibacumab biosimilar) |
Clone | Raxibacumab |
Host Species | Recombinant |
Reactive Species | n/a |
Isotype | IgG1 lambda |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Bacillus Anthracis Protective Antigen Recombinant Antibody (Raxibacumab). Raxibacumab is a human monoclonal antibody intended for the prophylaxis and treatment of inhaled anthrax. Its efficacy has been proven in rabbits and monkeys. In December 2012 raxibacumab was approved in the United States for the treatment of inhalational anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs, and for prophylaxis of inhalational anthrax when alternative therapies are not available or are not appropriate. |
Immunogen | n/a |
Other Names | Anti-Protective Antigen Recombinant Antibody, Research Grade Raxibacumab, Anti-Bacillus Anthracis Protective Antigen Recombinant Antibody(Raxibacumab), , Antibody Drug Analogues, Monoclonal Antibody, YR1171, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 565451-13-0 |
Catalog # | YR1171 |
Price | please inquire |
Order / More Info | Anthrax protective antigen, Bacillus anthracis (Raxibacumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |